Hefei Innovation Pharmaceutical Technology

Hefei Innovation Pharmaceutical Technology Co., Ltd. is a Chinese pharmaceutical research and development company established in 2001 and based in Hefei, Anhui. The company specializes in the development of chemical drugs and traditional Chinese medicines (TCM), providing a full suite of CRO and CDMO services including drug discovery, process optimization, and clinical research. It is recognized as a national high-tech enterprise and operates a dedicated R&D center alongside manufacturing facilities through its subsidiary, Anhui Bonomedical. Hefei Innovation is listed on the Anhui Equity Exchange and focuses on therapeutic areas such as oncology, cardiovascular diseases, and immune disorders. Its portfolio includes generic drug development for products like Olaparib and Vardenafil, as well as a pipeline of innovative TCM candidates. The company aims to bridge the gap between laboratory research and industrial-scale production through its integrated R&D and manufacturing platform.